Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Empowering Precision-medicine approach through NETs Plasma Biomarker-driven personalized treatment

Key Takeaway: The presentation titled 'Empowering Precision-medicine approach through NETs Plasma Biomarker-driven personalized treatment' was delivered by Dr. E. J. Giamarellos-Bourboulis at EHSF 2026. It emphasizes the significance of using NETs plasma biomarkers to tailor personalized treatment strategies, potentially enhancing patient care in oncology.
Price reaction · baseline $4.94 (2026-02-05 close) · hit pre-market · 3 other VNRX headline(s) in the window, move may be shared
day 0 close
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation highlights innovative precision-medicine approach.
  • Focus on NETs plasma biomarkers for personalized treatment.
  • Potential for improved patient outcomes in cancer treatment.

Full Press Release Details

Presentation titled: Empowering Precision-medicine approach through NETs Plasma Biomarker-driven personalized treatment
Ε. J. Giamarellos-Bourboulis, MD, PhD
Presented at EHSF 2026

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the presentation?

The presentation focused on using NETs plasma biomarkers for personalized treatment.

Who presented at EHSF 2026?

Dr. E. J. Giamarellos-Bourboulis presented at EHSF 2026.

What is the potential benefit of this approach?

This approach may enhance patient outcomes in cancer treatment.

Last updated: Feb 6, 2026